Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains

Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains

US Patent 10323081 · Granted Jun 18, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Agent, uses and methods for treatment2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025
Method for producing a controlled mixture of two or more different antibodies2025
Bispecific EGFR/c-Met antibodies2025
Anti-DR5 antibodies and methods of use thereof2025
Polypeptide variants and uses thereof2024
Bispecific antibodies for use in the treatment of hematological malignancies2024
Multispecific antibodies against CD40 and CD1372024
Antibody variants and uses thereof2024